PVC Burden Percentage Calculator

Clinical calculation support · Verify results before clinical use

PVC burden calculation

Enter counts from the same ambulatory ECG/Holter recording period. The result is the percentage of recorded beats that were PVCs.

% Burden
Number of premature ventricular contractions reported by the ECG/Holter analysis.
Use the total beat count for the same monitoring interval as the PVC count. Must be greater than zero.

Clinical context

PVC burden is the proportion of all recorded heartbeats represented by premature ventricular contractions during the selected monitoring period. The calculation describes frequency; it does not independently diagnose PVC-induced cardiomyopathy or determine treatment.

How to interpret the number

Calculated burdenClinical context
<1%Low numerical burden. Interpret alongside symptoms, PVC characteristics, and any underlying heart disease.
1% to <10%Below the commonly cited 10% threshold; clinical significance depends on the patient and the overall evaluation.
10% to 20%At or above the commonly cited threshold at which PVC-induced cardiomyopathy should be considered, particularly if LV function is impaired.
>20%Higher burden associated with greater likelihood of PVC-induced cardiomyopathy in published evidence; not a stand-alone diagnosis or treatment indication.

Important: These bands are explanatory reference ranges, not a validated universal grading system. A burden below 10% does not rule out PVC-related LV dysfunction in every patient.

Clinical considerations

  • Correlate with symptoms, 12-lead ECG, echocardiography, and the presence or absence of structural heart disease.
  • Consider day-to-day variation and recording duration; a single 24-hour recording may not fully represent the usual burden.
  • In unexplained reduced LVEF with a PVC burden of 10% or more, consider PVC-induced cardiomyopathy and further evaluation as appropriate.

References

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal. 2022;43(40):3997–4126. DOI: 10.1093/eurheartj/ehac262.
Cronin EM, Kanj M, Schuller JL, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020;17(1):e2–e154. Full text: PubMed Central.
Clinical disclaimer: This calculator provides a mathematical estimate of PVC burden and educational context only. It is not a substitute for clinical assessment or a treatment recommendation. Interpret results in the context of symptoms, ECG findings, ventricular function, structural heart disease, and the quality and duration of the monitoring recording.